It launched an “affordable drugs” campaignExternal link to pressure the Swiss Federal Council to introduce compulsory licencing, an instrument which allows cheaper generic medications to be introduced to the market despite the existence of a patent.
Public Eye argues the Swiss government has for too long put the interest of the pharmaceutical industry before the needs of the patients both in Switzerland and abroad.
It accused the authorities of being influenced by the “aggressive lobbying carried out by large Basel-based companies,” which are responsible for sky-rocketing prices.
Introducing compulsory licensing in Switzerland would make the Swiss healthcare system more sustainable, “send a strong signal to the international community and allow access to essential drugs for millions of people”, Public Eye wrote.
The appeal is backed by the Swiss Cancer League, numerous experts in the field and well-known Swiss politicians, such as former Federal Councillor Ruth Dreifuss.
More
More
Wanted: Pharma super cops
This content was published on
Have experience in tackling cybercrime, extremism, extortion, blackmail and bribery? If yes, the Swiss pharma industry might want to hear from you.
Swatch shareholders reject board bid by Steven Wood
This content was published on
At the Swiss watchmaker’s Annual General Meeting on Wednesday, 79.2% of votes cast opposed his election to the supervisory board.
WHO members agree to 20% rise in mandatory contributions
This content was published on
If the resolution is backed in the plenary session, the organisation’s budget for 2026-2027 will rise to CHF4.2 billion ($5.1 billion).
Japanese inflatable concert hall heads to Switzerland for the first time
This content was published on
The Ark Nova has been assembled four times to date – each time in a Japanese city. But this September, it’s heading to the Lucerne Festival.
Swiss government pledges CHF11 million to UNRWA amid Gaza crisis
This content was published on
Switzerland will contribute CHF20 million to meet urgent humanitarian needs in the occupied Palestinian territory and to support UNRWA operations.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Swiss pharma suspected of delaying generic competition
This content was published on
The United States Food and Drug Administration (FDA) lists Novartis and Roche among drug-makers suspected of hindering generic competition.
This content was published on
Each year, some half a million people die of malaria, many of them children. Switzerland is a world leader in research to combat the disease.
This content was published on
Links between parliamentarians in Bern and lobby groups have grown by 20% between 2007 and 2015, according to a new study.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.